QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☒ | Accelerated filer | ☐ | ||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||
Emerging growth company |
Page | ||||||||
July 3, 2021 | January 2, 2021 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net of allowances of $ | |||||||||||
Inventories | |||||||||||
Income taxes receivable | |||||||||||
Prepaid expenses | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Non-current assets: | |||||||||||
Property and equipment, net | |||||||||||
Operating lease right-of-use assets | |||||||||||
Goodwill and intangible assets, net | |||||||||||
Other non-current assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities and Shareholders’ Deficit | |||||||||||
Current liabilities: | |||||||||||
Borrowings under credit facility | $ | $ | |||||||||
Accounts payable | |||||||||||
Customer prepayments | |||||||||||
Accrued sales returns | |||||||||||
Compensation and benefits | |||||||||||
Taxes and withholding | |||||||||||
Operating lease liabilities | |||||||||||
Other current liabilities | |||||||||||
Total current liabilities | |||||||||||
Non-current liabilities: | |||||||||||
Deferred income taxes | |||||||||||
Operating lease liabilities | |||||||||||
Other non-current liabilities | |||||||||||
Total liabilities | |||||||||||
Shareholders’ deficit: | |||||||||||
Undesignated preferred stock; | |||||||||||
Common stock, $ | |||||||||||
Additional paid-in capital | |||||||||||
Accumulated deficit | ( | ( | |||||||||
Total shareholders’ deficit | ( | ( | |||||||||
Total liabilities and shareholders’ deficit | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Net sales | $ | $ | $ | $ | |||||||||||||||||||
Cost of sales | |||||||||||||||||||||||
Gross profit | |||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Sales and marketing | |||||||||||||||||||||||
General and administrative | |||||||||||||||||||||||
Research and development | |||||||||||||||||||||||
Total operating expenses | |||||||||||||||||||||||
Operating income (loss) | ( | ||||||||||||||||||||||
Interest expense, net | |||||||||||||||||||||||
Income (loss) before income taxes | ( | ||||||||||||||||||||||
Income tax expense (benefit) | ( | ||||||||||||||||||||||
Net income (loss) | $ | $ | ( | $ | $ | ||||||||||||||||||
Basic net income (loss) per share: | |||||||||||||||||||||||
Net income (loss) per share – basic | $ | $ | ( | $ | $ | ||||||||||||||||||
Weighted-average shares – basic | |||||||||||||||||||||||
Diluted net income (loss) per share: | |||||||||||||||||||||||
Net income (loss) per share – diluted | $ | $ | ( | $ | $ | ||||||||||||||||||
Weighted-average shares – diluted |
Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total | ||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||
Balance at January 2, 2021 | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||
Net income | — | — | — | ||||||||||||||||||||||||||
Exercise of common stock options | — | ||||||||||||||||||||||||||||
Stock-based compensation | — | ||||||||||||||||||||||||||||
Repurchases of common stock | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balance at April 3, 2021 | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||
Net income | — | — | — | ||||||||||||||||||||||||||
Exercise of common stock options | — | — | |||||||||||||||||||||||||||
Stock-based compensation | — | ||||||||||||||||||||||||||||
Repurchases of common stock | ( | (9) | ( | ( | ( | ||||||||||||||||||||||||
Balance at July 3, 2021 | $ | $ | $ | ( | $ | ( |
Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total | ||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||
Balance at December 28, 2019 | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||
Net income | — | — | — | ||||||||||||||||||||||||||
Exercise of common stock options | — | ||||||||||||||||||||||||||||
Stock-based compensation | — | ||||||||||||||||||||||||||||
Repurchases of common stock | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balance at March 28, 2020 | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||
Net loss | — | — | — | ( | ( | ||||||||||||||||||||||||
Exercise of common stock options | — | — | |||||||||||||||||||||||||||
Stock-based compensation | — | ||||||||||||||||||||||||||||
Repurchases of common stock | ( | — | ( | ( | |||||||||||||||||||||||||
Balance at June 27, 2020 | $ | $ | $ | ( | $ | ( | |||||||||||||||||||||||
Six Months Ended | |||||||||||
July 3, 2021 | June 27, 2020 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | |||||||||||
Stock-based compensation | |||||||||||
Net loss on disposals and impairments of assets | |||||||||||
Deferred income taxes | |||||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | |||||||||||
Inventories | ( | ||||||||||
Income taxes | ( | ||||||||||
Prepaid expenses and other assets | ( | ||||||||||
Accounts payable | ( | ||||||||||
Customer prepayments | |||||||||||
Accrued compensation and benefits | ( | ( | |||||||||
Other taxes and withholding | ( | ||||||||||
Other accruals and liabilities | |||||||||||
Net cash provided by operating activities | |||||||||||
Cash flows from investing activities: | |||||||||||
Purchases of property and equipment | ( | ( | |||||||||
Proceeds from sales of property and equipment | |||||||||||
Purchase of intangible assets | ( | ||||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Repurchases of common stock | ( | ( | |||||||||
Net increase (decrease) in short-term borrowings | ( | ||||||||||
Proceeds from issuance of common stock | |||||||||||
Debt issuance costs | ( | ( | |||||||||
Net cash used in financing activities | ( | ( | |||||||||
Net (decrease) increase in cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents, at beginning of period | |||||||||||
Cash and cash equivalents, at end of period | $ | $ |
July 3, 2021 | January 2, 2021 | ||||||||||
Raw materials | $ | $ | |||||||||
Work in progress | |||||||||||
Finished goods | |||||||||||
$ | $ |
2021 (excluding the six months ended July 3, 2021) | $ | |||||||
2022 | ||||||||
2023 | ||||||||
2024 | ||||||||
2025 | ||||||||
2026 | ||||||||
Thereafter | ||||||||
Total future amortization for definite-lived intangible assets | $ |
July 3, 2021 | January 2, 2021 | ||||||||||
Outstanding borrowings | $ | $ | |||||||||
Outstanding letters of credit | $ | $ | |||||||||
Additional borrowing capacity | $ | $ | |||||||||
Weighted-average interest rate | % | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Operating lease costs(1) | $ | $ | $ | $ | |||||||||||||||||||
Variable lease costs | $ | $ | $ | $ |
2021 (excluding the six months ended July 3, 2021) | $ | ||||
2022 | |||||
2023 | |||||
2024 | |||||
2025 | |||||
2026 | |||||
Thereafter | |||||
Total operating lease payments(2) | |||||
Less: Interest | |||||
Present value of operating lease liabilities(3) | $ |
July 3, 2021 | January 2, 2021 | |||||||||||||
Weighted-average remaining lease term (years) | ||||||||||||||
Weighted-average discount rate | % | % |
Six Months Ended | ||||||||||||||
(in thousands) | July 3, 2021 | June 27, 2020 | ||||||||||||
Cash paid for amounts included in present value of operating lease liabilities | $ | $ | ||||||||||||
Right-of-use assets obtained in exchange for operating lease liabilities | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Amount repurchased under Board-approved share repurchase program | $ | $ | $ | $ | |||||||||||||||||||
Amount repurchased in connection with the vesting of employee restricted stock grants | |||||||||||||||||||||||
Total amount repurchased (based on trade dates) | $ | $ | $ | $ |
July 3, 2021 | January 2, 2021 | ||||||||||
Deferred Contract Assets included in: | |||||||||||
Other current assets | $ | $ | |||||||||
Other non-current assets | |||||||||||
$ | $ |
July 3, 2021 | January 2, 2021 | ||||||||||
Deferred Contract Liabilities included in: | |||||||||||
Other current liabilities | $ | $ | |||||||||
Other non-current liabilities | |||||||||||
$ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Retail stores | $ | $ | $ | $ | |||||||||||||||||||
Online, phone, chat and other | |||||||||||||||||||||||
Total Company | $ | $ | $ | $ |
Six Months Ended | |||||||||||
July 3, 2021 | June 27, 2020 | ||||||||||
Balance at beginning of year | $ | $ | |||||||||
Additions that reduce net sales | |||||||||||
Deductions from reserves | ( | ( | |||||||||
Balance at end of period | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Stock awards | $ | $ | $ | ||||||||||||||||||||
Stock options | |||||||||||||||||||||||
Total stock-based compensation expense (1) | |||||||||||||||||||||||
Income tax benefit | |||||||||||||||||||||||
Total stock-based compensation expense, net of tax | $ | $ | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Net income (loss) | $ | $ | ( | $ | $ | ||||||||||||||||||
Reconciliation of weighted-average shares outstanding: | |||||||||||||||||||||||
Basic weighted-average shares outstanding | |||||||||||||||||||||||
Dilutive effect of stock-based awards | |||||||||||||||||||||||
Diluted weighted-average shares outstanding | |||||||||||||||||||||||
Net income (loss) per share – basic | $ | $ | ( | $ | $ | ||||||||||||||||||
Net income (loss) per share – diluted | $ | $ | ( | $ | $ |
Six Months Ended | |||||||||||
July 3, 2021 | June 27, 2020 | ||||||||||
Balance at beginning of year | $ | $ | |||||||||
Additions charged to costs and expenses for current-year sales | |||||||||||
Deductions from reserves | ( | ( | |||||||||
Changes in liability for pre-existing warranties during the current year, including expirations | ( | ( | |||||||||
Balance at end of period | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
Net sales | $ | 484.3 | 100.0 | % | $ | 284.9 | 100.0 | % | $ | 1,052.6 | 100.0 | % | $ | 757.5 | 100.0 | % | |||||||||||||||||||||||||||||||
Cost of sales | 191.5 | 39.5 | % | 121.9 | 42.8 | % | 403.8 | 38.4 | % | 292.4 | 38.6 | % | |||||||||||||||||||||||||||||||||||
Gross profit | 292.9 | 60.5 | % | 163.0 | 57.2 | % | 648.8 | 61.6 | % | 465.1 | 61.4 | % | |||||||||||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
Sales and marketing | 206.0 | 42.5 | % | 130.2 | 45.7 | % | 429.6 | 40.8 | % | 337.9 | 44.6 | % | |||||||||||||||||||||||||||||||||||
General and administrative | 41.2 | 8.5 | % | 36.7 | 12.9 | % | 83.8 | 8.0 | % | 67.8 | 8.9 | % | |||||||||||||||||||||||||||||||||||
Research and development | 15.9 | 3.3 | % | 8.3 | 2.9 | % | 29.2 | 2.8 | % | 18.8 | 2.5 | % | |||||||||||||||||||||||||||||||||||
Total operating expenses | 263.1 | 54.3 | % | 175.1 | 61.5 | % | 542.6 | 51.6 | % | 424.5 | 56.0 | % | |||||||||||||||||||||||||||||||||||
Operating income (loss) | 29.7 | 6.1 | % | (12.1) | (4.3 | %) | 106.1 | 10.1 | % | 40.7 | 5.4 | % | |||||||||||||||||||||||||||||||||||
Interest expense, net | 1.6 | 0.3 | % | 3.9 | 1.4 | % | 2.6 | 0.2 | % | 6.3 | 0.8 | % | |||||||||||||||||||||||||||||||||||
Income (loss) before income taxes | 28.1 | 5.8 | % | (16.1) | (5.6 | %) | 103.6 | 9.8 | % | 34.4 | 4.5 | % | |||||||||||||||||||||||||||||||||||
Income tax expense (benefit) | 5.9 | 1.2 | % | (3.4) | (1.2 | %) | 14.7 | 1.4 | % | 7.9 | 1.0 | % | |||||||||||||||||||||||||||||||||||
Net income (loss) | $ | 22.3 | 4.6 | % | $ | (12.6) | (4.4 | %) | $ | 88.9 | 8.4 | % | $ | 26.5 | 3.5 | % | |||||||||||||||||||||||||||||||
Net income (loss) per share: | |||||||||||||||||||||||||||||||||||||||||||||||
Basic | $ | 0.91 | $ | (0.45) | $ | 3.57 | $ | 0.95 | |||||||||||||||||||||||||||||||||||||||
Diluted | $ | 0.88 | $ | (0.45) | $ | 3.44 | $ | 0.93 | |||||||||||||||||||||||||||||||||||||||
Weighted-average number of common shares: | |||||||||||||||||||||||||||||||||||||||||||||||
Basic | 24.4 | 27.9 | 24.9 | 27.9 | |||||||||||||||||||||||||||||||||||||||||||
Diluted | 25.2 | 27.9 | 25.9 | 28.5 |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Retail stores | 88.1 | % | 72.2 | % | 87.0 | % | 84.6 | % | |||||||||||||||
Online, phone, chat and other | 11.9 | % | 27.8 | % | 13.0 | % | 15.4 | % | |||||||||||||||
Total Company | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Sales change rates: | |||||||||||||||||||||||
Retail comparable-store sales (1) | 102 | % | (40 | %) | 41 | % | (14 | %) | |||||||||||||||
Online, phone and chat | (28 | %) | 209 | % | 17 | % | 107 | % | |||||||||||||||
Total Retail comparable sales change (1) | 65 | % | (21 | %) | 37 | % | (5 | %) | |||||||||||||||
Net opened/closed stores and other | 5 | % | 1 | % | 2 | % | 2 | % | |||||||||||||||
Total Company | 70 | % | (20 | %) | 39 | % | (3 | %) |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Average sales per store (1)(4) ($ in thousands) | $ | 3,542 | $ | 2,830 | |||||||||||||||||||
Average sales per square foot (1)(4) | $ | 1,203 | $ | 988 | |||||||||||||||||||
Stores > $2 million in net sales (2)(4) | 82 | % | 63 | % | |||||||||||||||||||
Stores > $3 million in net sales (2)(4) | 47 | % | 25 | % | |||||||||||||||||||
Average revenue per mattress unit (3) | $ | 5,094 | $ | 4,767 | $ | 5,059 | $ | 4,839 |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Beginning of period | 607 | 611 | 602 | 611 | |||||||||||||||||||
Opened | 26 | 6 | 37 | 14 | |||||||||||||||||||
Closed | (12) | (19) | (18) | (27) | |||||||||||||||||||
End of period | 621 | 598 | 621 | 598 |
Six Months Ended | |||||||||||
July 3, 2021 | June 27, 2020 | ||||||||||
Total cash provided by (used in): | |||||||||||
Operating activities | $ | 161.4 | $ | 87.0 | |||||||
Investing activities | (32.0) | (22.6) | |||||||||
Financing activities | (131.5) | (64.3) | |||||||||
Net (decrease) increase in cash and cash equivalents | $ | (2.1) | $ | 0.1 |
Three Months Ended | Fifty-Three Weeks Ended | Fifty-Two Weeks Ended | |||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Net income (loss) | $ | 22,250 | $ | (12,630) | $ | 201,563 | $ | 78,657 | |||||||||||||||
Income tax expense (benefit) | 5,864 | (3,435) | 43,564 | 22,141 | |||||||||||||||||||
Interest expense | 1,607 | 4,022 | 5,227 | 12,131 | |||||||||||||||||||
Depreciation and amortization | 15,006 | 15,253 | 59,802 | 60,951 | |||||||||||||||||||
Stock-based compensation | 5,968 | 5,033 | 27,114 | 15,853 | |||||||||||||||||||
Asset impairments | — | 246 | 142 | 294 | |||||||||||||||||||
Adjusted EBITDA | $ | 50,695 | $ | 8,489 | $ | 337,412 | $ | 190,027 |
Six Months Ended | Fifty-Three Weeks Ended | Fifty-Two Weeks Ended | |||||||||||||||||||||
July 3, 2021 | June 27, 2020 | July 3, 2021 | June 27, 2020 | ||||||||||||||||||||
Net cash provided by operating activities | $ | 161,420 | $ | 87,001 | $ | 354,080 | $ | 205,814 | |||||||||||||||
Subtract: Purchases of property and equipment | 32,012 | 21,695 | 47,417 | 47,038 | |||||||||||||||||||
Free cash flow | $ | 129,408 | $ | 65,306 | $ | 306,663 | $ | 158,776 |
Fifty-Three Weeks Ended | Fifty-Two Weeks Ended | ||||||||||
July 3, 2021 | June 27, 2020 | ||||||||||
Net operating profit after taxes (NOPAT) | |||||||||||
Operating income | $ | 250,352 | $ | 112,831 | |||||||
Add: Rent expense (1) | 95,226 | 90,349 | |||||||||
Add: Interest income | 2 | 97 | |||||||||
Less: Depreciation on capitalized operating leases (2) | (24,577) | (23,331) | |||||||||
Less: Income taxes (3) | (76,939) | (42,735) | |||||||||
NOPAT | $ | 244,064 | $ | 137,211 | |||||||
Average invested capital | |||||||||||
Total deficit | $ | (403,658) | $ | (163,018) | |||||||
Add: Long-term debt (4) | 382,794 | 227,944 | |||||||||
Add: Capitalized operating lease obligations (5) | 761,808 | 722,792 | |||||||||
Total invested capital at end of period | $ | 740,944 | $ | 787,718 | |||||||
Average invested capital (6) | $ | 733,151 | $ | 797,862 | |||||||
Return on invested capital (ROIC) (7) | 33.3 | % | 17.2 | % |
Period | Total Number of Shares Purchased(1)(2) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(3) | ||||||||||||||||||||||
April 4, 2021 through May 1, 2021 | 182,833 | $ | 118.52 | 181,923 | $ | 578,438,000 | ||||||||||||||||||||
May 2, 2021 through May 29, 2021 | 329,735 | $ | 108.23 | 329,468 | $ | 542,779,000 | ||||||||||||||||||||
May 30, 2021 through July 3, 2021 | 386,128 | $ | 111.20 | 384,840 | $ | 499,985,000 | ||||||||||||||||||||
Total | 898,696 | $ | 111.59 | 896,231 | $ | 499,985,000 |
Exhibit Number | Description | |||||||
31.1* | ||||||||
31.2* | ||||||||
32.1* | ||||||||
32.2* | ||||||||
101.INS* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |||||||
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |||||||
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104* | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
SLEEP NUMBER CORPORATION | |||||||||||
(Registrant) | |||||||||||
Dated: | July 30, 2021 | By: | /s/ Shelly R. Ibach | ||||||||
Shelly R. Ibach | |||||||||||
Chief Executive Officer | |||||||||||
(principal executive officer) | |||||||||||
By: | /s/ Robert J. Poirier | ||||||||||
Robert J. Poirier | |||||||||||
Chief Accounting Officer | |||||||||||
(principal accounting officer) |
Date: July 30, 2021 | |||||
/s/ Shelly R. Ibach | |||||
Shelly R. Ibach | |||||
Chief Executive Officer |
Date: July 30, 2021 | |||||
/s/ David R. Callen | |||||
David R. Callen | |||||
Executive Vice President and Chief Financial Officer |
Date: July 30, 2021 | |||||
/s/ Shelly R. Ibach | |||||
Shelly R. Ibach | |||||
Chief Executive Officer |
Date: July 30, 2021 | |||||
/s/ David R. Callen | |||||
David R. Callen | |||||
Executive Vice President and Chief Financial Officer |
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Current assets: | ||
Allowances | $ 1,098 | $ 1,046 |
Shareholders’ deficit: | ||
Undesignated preferred stock, shares authorized (in shares) | 5,000 | 5,000 |
Undesignated preferred stock, shares issued (in shares) | 0 | 0 |
Undesignated preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 142,500,000 | 142,500,000 |
Common stock, shares issued (in shares) | 23,622,000 | 25,390,000 |
Common stock, shares outstanding (in shares) | 23,622,000 | 25,390,000 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Income Statement [Abstract] | ||||
Net sales | $ 484,316 | $ 284,938 | $ 1,052,572 | $ 757,504 |
Cost of sales | 191,465 | 121,928 | 403,803 | 292,363 |
Gross profit | 292,851 | 163,010 | 648,769 | 465,141 |
Operating expenses: | ||||
Sales and marketing | 205,994 | 130,165 | 429,611 | 337,909 |
General and administrative | 41,220 | 36,716 | 83,812 | 67,788 |
Research and development | 15,916 | 8,254 | 29,202 | 18,755 |
Total operating expenses | 263,130 | 175,135 | 542,625 | 424,452 |
Operating income (loss) | 29,721 | (12,125) | 106,144 | 40,689 |
Interest expense, net | 1,607 | 3,940 | 2,584 | 6,284 |
Income (loss) before income taxes | 28,114 | (16,065) | 103,560 | 34,405 |
Income tax expense (benefit) | 5,864 | (3,435) | 14,676 | 7,895 |
Net income (loss) | $ 22,250 | $ (12,630) | $ 88,884 | $ 26,510 |
Basic net income (loss) per share: | ||||
Net income (loss) per share – basic (in dollars per share) | $ 0.91 | $ (0.45) | $ 3.57 | $ 0.95 |
Weighted-average shares – basic (in shares) | 24,371,000 | 27,923,000 | 24,874,000 | 27,890,000 |
Diluted net income (loss) per share: | ||||
Net income (loss) per share – diluted (in dollars per share) | $ 0.88 | $ (0.45) | $ 3.44 | $ 0.93 |
Weighted-average shares – diluted (in shares) | 25,194,000 | 27,923,000 | 25,869,000 | 28,523,000 |
Business and Summary of Significant Accounting Policies |
6 Months Ended |
---|---|
Jul. 03, 2021 | |
Accounting Policies [Abstract] | |
Business and Summary of Significant Accounting Policies | Business and Summary of Significant Accounting Policies Business & Basis of Presentation We prepared the condensed consolidated financial statements as of and for the three and six months ended July 3, 2021 of Sleep Number Corporation and our 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of July 3, 2021 and January 2, 2021, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period. Additionally, based on the duration and severity of the current global situation involving the novel coronavirus (COVID-19) pandemic, including but not limited to general economic conditions, consumer confidence, store restrictions mandated by federal, state or local authorities and possible supply chain disruptions, the extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 2, 2021 and other recent filings with the SEC. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. In addition, during the current environment involving COVID-19, predicting future events will be especially challenging for management. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material. Our critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition. The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.
|
Fair Value Measurements |
6 Months Ended |
---|---|
Jul. 03, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value MeasurementsAt July 3, 2021 and January 2, 2021, we had $17 million and $12 million, respectively, of debt and equity securities that fund our deferred compensation plan and are classified in other non-current assets. We also had corresponding deferred compensation plan liabilities of $17 million and $12 million at July 3, 2021 and January 2, 2021, respectively, which are included in other non-current liabilities. The majority of the debt and equity securities are Level 1 as they trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis. Unrealized gains/(losses) on the debt and equity securities offset those associated with the corresponding deferred compensation plan liabilities. |
Inventories |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | InventoriesInventories consisted of the following (in thousands):
|
Goodwill and Intangible Assets, Net |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets, Net | Goodwill and Intangible Assets, Net Goodwill and Indefinite-lived Intangible Assets Goodwill was $64 million at July 3, 2021 and January 2, 2021. Indefinite-lived trade name/trademarks totaled $1.4 million at July 3, 2021 and January 2, 2021. Definite-lived Intangible Assets The gross carrying amount of our developed technologies was $19 million at July 3, 2021 and January 2, 2021. Accumulated amortization was $14 million and $13 million at July 3, 2021 and January 2, 2021, respectively. Amortization expense for both the three months ended July 3, 2021 and June 27, 2020, was $0.5 million. Amortization expense for both the six months ended July 3, 2021 and June 27, 2020, was $1.1 million. The gross carrying amount of our patents, which were acquired in June 2020, was $2.0 million at July 3, 2021 and January 2, 2021, respectively. Accumulated amortization was $0.2 million and $0.1 million at July 3, 2021 and January 2, 2021, respectively. Amortization expense for the three and six months ended July 3, 2021 was $55 thousand and $0.1 million, respectively. Amortization expense for the three and six months ended June 27, 2020 was not significant. Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):
|
Credit Agreement |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit Agreement | Credit Agreement Our credit facility as of July 3, 2021, has a net aggregate commitment amount of $600 million. The credit facility is for general corporate purposes, to meet our seasonal working capital requirements and to repurchase our stock. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio (4.5x) and a minimum interest coverage ratio (3.0x). The credit agreement includes an accordion feature which allows us to increase the amount of the credit facility from $600 million to $800 million, subject to lenders' approval. Under the terms of the credit agreement, we pay a variable rate of interest and a commitment fee based on our leverage ratio. We were in compliance with all financial covenants as of July 3, 2021. The credit facility matures in February 2024. The following table summarizes our borrowings under the credit facility ($ in thousands):
|
Leases |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases | Leases We lease our retail, office and manufacturing space under operating leases which, in addition to the minimum lease payments, may require payment of a proportionate share of the real estate taxes and certain building operating expenses. While our local market development approach generally results in long-term participation in given markets, our retail store leases generally provide for an initial lease term of to 10 years. Our office and manufacturing leases provide for an initial lease term of up to 15 years. In addition, our mall-based retail store leases may require payment of variable rent based on net sales in excess of certain thresholds. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at our sole discretion. Lease options are included in the lease term only if exercise is reasonably certain at lease commencement. Our lease agreements do not contain any material residual value guarantees. We also lease vehicles and certain equipment under operating leases with an initial lease term of to five years. Our operating lease costs include facility, vehicle and equipment lease costs, but exclude variable lease costs. Operating lease costs are recognized on a straight-line basis over the lease term, after consideration of rent escalations and rent holidays. The lease term for purposes of the calculation begins on the earlier of the lease commencement date or the date we take possession of the property. During lease renewal negotiations that extend beyond the original lease term, we estimate straight-line rent expense based on current market conditions. Variable lease costs are recorded when it is probable the cost has been incurred and the amount can be reasonably estimated. Future payments for real estate taxes and certain building operating expenses for which we are obligated are not included in operating lease costs. At July 3, 2021, our finance right-of-use assets and lease liabilities were not significant. Lease costs were as follows (in thousands):
___________________________ (1)Includes short-term lease costs which are not significant. The maturities of operating lease liabilities as of July 3, 2021, were as follows(1) (in thousands):
___________________________ (1)During 2020, we deferred certain cash lease payments to future periods. At July 3, 2021, we had deferred cash rent payments of $1.6 million which are excluded from this table and are included in Other current liabilities and Other non-current liabilities. (2)Total operating lease payments exclude $78 million of legally binding minimum lease payments for leases signed but not yet commenced. (3)Includes the current portion of $68 million for operating lease liabilities. Other information related to operating leases was as follows:
|
Repurchases of Common Stock |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchases Of Common Stock [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchases of Common Stock | Repurchases of Common Stock Repurchases of our common stock were as follows (in thousands):
As of July 3, 2021, the remaining authorization under the $600 million share repurchase program was $500 million.
|
Revenue Recognition |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | Revenue Recognition Deferred contract assets and deferred contract liabilities are included in our condensed consolidated balance sheets as follows (in thousands):
The deferred revenue and costs related to SleepIQ technology are recognized on a straight-line basis over the product's estimated life of 4.5 years because our inputs are generally expended evenly throughout the performance period. During the three months ended July 3, 2021 and June 27, 2020, we recognized revenue of $8 million and $10 million, respectively, that were included in the deferred contract liability balances at the beginning of the respective periods. During the six months ended July 3, 2021 and June 27, 2020, we recognized revenue of $15 million and $18 million, respectively, that were included in the deferred contract liability balances at the beginning of the respective periods. Revenue from goods and services transferred to customers at a point in time accounted for approximately 98% of our revenues for the three and six months ended July 3, 2021 and 97% of our revenues for the three and six months ended June 27, 2020. Net sales were as follows (in thousands):
Obligation for Sales Returns The activity in the sales returns liability account was as follows (in thousands):
|
Stock-based Compensation Expense |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based Compensation Expense | Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands):
___________________________ (1) Changes in stock-based compensation expense reflect the cumulative impact of the change in the expected achievements of certain performance targets.
|
Profit Sharing and 401(k) Plan |
6 Months Ended |
---|---|
Jul. 03, 2021 | |
Profit Sharing And 401 (k) Plan [Abstract] | |
Profit Sharing and 401(k) Plan | Profit Sharing and 401(k) PlanUnder our profit sharing and 401(k) plan, eligible employees may defer up to 50% of their compensation on a pre-tax basis, subject to Internal Revenue Service limitations. Each pay period, we may make a discretionary contribution equal to a percentage of the employee’s contribution. During the three months ended July 3, 2021 and June 27, 2020, our contributions, net of forfeitures, were $1.8 million and $0.5 million, respectively. During the six months ended July 3, 2021 and June 27, 2020, our contributions, net of forfeitures, were $3.7 million and $2.1 million, respectively. |
Net Income (Loss) per Common Share |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income (Loss) per Common Share | Net Income (Loss) per Common Share The components of basic and diluted net income (loss) per share were as follows (in thousands, except per share amounts):
For the three and six months ended July 3, 2021 and the six months ended June 27, 2020, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial. For the three months ended June 27, 2020, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.
|
Commitments and Contingencies |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies Warranty Liabilities The activity in the accrued warranty liabilities account was as follows (in thousands):
Legal Proceedings We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with U.S. generally accepted accounting principles, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. If a material loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible material losses either because we believe that we have valid defenses to claims asserted against us, the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate, or the potential loss is not material. We currently do not expect the outcome of pending legal proceedings to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred. On March 27, 2018, Level Sleep, LLC (Level Sleep) filed a patent infringement lawsuit against Sleep Number in the Federal District Court for the Eastern District of Texas. In its Complaint, Level Sleep claims that Sleep Number infringed two patents owned by Level Sleep, U.S. Patent Nos. 6,807,698 and 7,036,172 (the Patents), by, among other things, making, using, offering for sale, or selling within the United States, and/or importing into the United States, beds with sleep surfaces having foam with multiple zones in the longitudinal direction. Level Sleep has asserted that five non-360® beds no longer sold and two current non-360 beds infringe the Patents. Level Sleep seeks damages in the form of a reasonable royalty. Sleep Number has asserted that the Patents are invalid and that our products do not infringe the Patents. On January 14, 2020, the Court granted summary judgment in favor of Sleep Number, finding that Sleep Number’s products do not infringe the Patents. Level Sleep filed an appeal of the Court’s summary judgment order to the Federal Circuit Court of Appeals which issued a decision on July 13, 2021, affirming the Court's summary judgment order and dismissal of Level Sleep's claims.
|
COVID-19 Pandemic |
6 Months Ended |
---|---|
Jul. 03, 2021 | |
Unusual or Infrequent Items, or Both [Abstract] | |
COVID-19 Pandemic | COVID-19 Pandemic At the onset of the COVID-19 pandemic in mid-March 2020, government restrictions resulted in the temporary closure of most of our retail stores, with 47% of our stores closed on average during the second quarter of 2020. While prioritizing the safety of our team, serving our customers and ensuring business continuity, we swiftly took decisive actions to strengthen our liquidity, cash flows and financial position, and mitigate the future impact on our operations and financial performance. The COVID-19 pandemic mainly impacted our second quarter of 2020 financial performance, as we generated strong financial performance during the full-year of 2020 and the first six months of 2021. However, the pandemic's future effect on consumer demand and our ongoing financial performance remains uncertain. See Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations of this Quarterly Report on Form 10-Q and Part I: Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended January 2, 2021, for additional discussion on the COVID-19 pandemic and the impact on our business.
|
Business and Summary of Significant Accounting Policies (Policies) |
6 Months Ended |
---|---|
Jul. 03, 2021 | |
Accounting Policies [Abstract] | |
Business and Basis of Presentation | Business & Basis of Presentation We prepared the condensed consolidated financial statements as of and for the three and six months ended July 3, 2021 of Sleep Number Corporation and our 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of July 3, 2021 and January 2, 2021, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period. Additionally, based on the duration and severity of the current global situation involving the novel coronavirus (COVID-19) pandemic, including but not limited to general economic conditions, consumer confidence, store restrictions mandated by federal, state or local authorities and possible supply chain disruptions, the extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 2, 2021 and other recent filings with the SEC.
|
Use of Estimates | The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. In addition, during the current environment involving COVID-19, predicting future events will be especially challenging for management. Changes in these estimates will be reflected in the consolidated financial statements in future periods and could be material. Our critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition. |
Consolidation | The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation. |
Leases | We lease our retail, office and manufacturing space under operating leases which, in addition to the minimum lease payments, may require payment of a proportionate share of the real estate taxes and certain building operating expenses. While our local market development approach generally results in long-term participation in given markets, our retail store leases generally provide for an initial lease term of to 10 years. Our office and manufacturing leases provide for an initial lease term of up to 15 years. In addition, our mall-based retail store leases may require payment of variable rent based on net sales in excess of certain thresholds. Certain leases may contain options to extend the term of the original lease. The exercise of lease renewal options is at our sole discretion. Lease options are included in the lease term only if exercise is reasonably certain at lease commencement. Our lease agreements do not contain any material residual value guarantees. We also lease vehicles and certain equipment under operating leases with an initial lease term of to five years. Our operating lease costs include facility, vehicle and equipment lease costs, but exclude variable lease costs. Operating lease costs are recognized on a straight-line basis over the lease term, after consideration of rent escalations and rent holidays. The lease term for purposes of the calculation begins on the earlier of the lease commencement date or the date we take possession of the property. During lease renewal negotiations that extend beyond the original lease term, we estimate straight-line rent expense based on current market conditions. Variable lease costs are recorded when it is probable the cost has been incurred and the amount can be reasonably estimated. Future payments for real estate taxes and certain building operating expenses for which we are obligated are not included in operating lease costs.
|
Inventories (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories | Inventories consisted of the following (in thousands):
|
Goodwill and Intangible Assets, Net (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Annual Amortization of Definite-Lived Tangible Assets | Annual amortization for definite-lived intangible assets for subsequent years are as follows (in thousands):
|
Credit Agreement (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Borrowings Under Credit Facility | The following table summarizes our borrowings under the credit facility ($ in thousands):
|
Leases (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Operating Lease Costs | Lease costs were as follows (in thousands):
___________________________ (1)Includes short-term lease costs which are not significant.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Maturities of Operating Lease Liabilities | The maturities of operating lease liabilities as of July 3, 2021, were as follows(1) (in thousands):
___________________________ (1)During 2020, we deferred certain cash lease payments to future periods. At July 3, 2021, we had deferred cash rent payments of $1.6 million which are excluded from this table and are included in Other current liabilities and Other non-current liabilities. (2)Total operating lease payments exclude $78 million of legally binding minimum lease payments for leases signed but not yet commenced. (3)Includes the current portion of $68 million for operating lease liabilities.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Information Related Operating Leases | Other information related to operating leases was as follows:
|
Repurchases of Common Stock (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchases Of Common Stock [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Repurchases of Common Stock | Repurchases of our common stock were as follows (in thousands):
|
Revenue Recognition (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Deferred Contract Liabilities and Deferred Contract Assets | Deferred contract assets and deferred contract liabilities are included in our condensed consolidated balance sheets as follows (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue | Net sales were as follows (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Sales Return Liability | The activity in the sales returns liability account was as follows (in thousands):
|
Stock-based Compensation Expense (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Stock-Based Compensation Expense | Total stock-based compensation expense was as follows (in thousands):
___________________________ (1) Changes in stock-based compensation expense reflect the cumulative impact of the change in the expected achievements of certain performance targets.
|
Net Income (Loss) per Common Share (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Basic and Diluted Net (Loss) Income per Share | The components of basic and diluted net income (loss) per share were as follows (in thousands, except per share amounts):
|
Commitments and Contingencies (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 03, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warranty Liabilities | The activity in the accrued warranty liabilities account was as follows (in thousands):
|
Fair Value Measurements (Details) - Level 1 - USD ($) $ in Millions |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Other non-current assets | Available-for-sale securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities assets funding the deferred compensation plan | $ 17 | $ 12 |
Other non-current liabilities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Deferred compensation plan liability | $ 17 | $ 12 |
Inventories (Details) - USD ($) $ in Thousands |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Inventory Disclosure [Abstract] | ||
Raw materials | $ 7,730 | $ 12,599 |
Work in progress | 98 | 103 |
Finished goods | 80,749 | 68,660 |
Inventories | $ 88,577 | $ 81,362 |
Goodwill and Intangible Assets, Net - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jan. 02, 2021 |
|
Goodwill And Intangible Assets [Line Items] | ||||
Goodwill | $ 64,000 | $ 64,000 | $ 64,000 | |
Developed Technologies | ||||
Goodwill And Intangible Assets [Line Items] | ||||
Gross carrying amount | 19,000 | 19,000 | 19,000 | |
Accumulated amortization | 14,000 | 14,000 | 13,000 | |
Amortization expense | 500 | $ 500 | 1,100 | |
Patents | ||||
Goodwill And Intangible Assets [Line Items] | ||||
Gross carrying amount | 2,000 | 2,000 | 2,000 | |
Accumulated amortization | 200 | 200 | 100 | |
Amortization expense | 55 | 100 | ||
Trade Names | ||||
Goodwill And Intangible Assets [Line Items] | ||||
Indefinite-lived trade name/trademarks | $ 1,400 | $ 1,400 | $ 1,400 |
Goodwill and Intangible Assets, Net - Annual Amortization for Definite-Lived Intangible (Details) $ in Thousands |
3 Months Ended | 6 Months Ended |
---|---|---|
Jul. 03, 2021
USD ($)
|
Jul. 03, 2021
USD ($)
|
|
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | ||
2021 (excluding the six months ended July 3, 2021) | $ 1,201 | $ 1,201 |
2022 | 2,403 | 2,403 |
2023 | 1,431 | 1,431 |
2024 | 222 | 222 |
2025 | 226 | 226 |
2026 | 222 | 222 |
Thereafter | 522 | 522 |
Total future amortization for definite-lived intangible assets | 6,227 | 6,227 |
Patents | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortization expense | $ 55 | $ 100 |
Credit Agreement - Additional Information (Details) - USD ($) $ in Millions |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Debt Disclosure [Abstract] | ||
Current borrowing capacity | $ 600 | |
Maximum leverage ratio | 450.00% | |
Minimum interest coverage ratio | 300.00% | |
Total commitment amount | $ 800 | $ 600 |
Credit Agreement - Schedule of Borrowings Under Credit Facility (Details) - USD ($) $ in Thousands |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Debt Disclosure [Abstract] | ||
Outstanding borrowings | $ 382,200 | $ 244,200 |
Outstanding letters of credit | 3,997 | 3,997 |
Additional borrowing capacity | $ 213,803 | $ 201,803 |
Weighted-average interest rate | 1.60% | 1.50% |
Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Leases [Abstract] | ||||
Operating lease costs | $ 24,352 | $ 22,357 | $ 47,991 | $ 45,303 |
Variable lease costs | $ 840 | $ 263 | $ 1,355 | $ 275 |
Leases - Schedule of Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Leases [Abstract] | ||
2021 (excluding the six months ended July 3, 2021) | $ 45,819 | |
2022 | 85,828 | |
2023 | 75,838 | |
2024 | 64,013 | |
2025 | 54,458 | |
2026 | 43,974 | |
Thereafter | 92,392 | |
Total lease payments | 462,322 | |
Less: Interest | 82,942 | |
Present value of operating lease liabilities | 379,380 | |
Amount of lease payments deferred due to COVID-19 | 1,600 | |
Amount leases executed, not yet commenced, excluded from table. | 78,000 | |
Operating lease liabilities, current | $ 67,648 | $ 62,077 |
Leases - Schedule of Other Information Related Operating Leases (Details) - USD ($) $ in Thousands |
6 Months Ended | ||
---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jan. 02, 2021 |
|
Leases [Abstract] | |||
Weighted-average remaining lease term (years) | 6 years 4 months 24 days | 6 years 3 months 18 days | |
Weighted-average discount rate | 6.50% | 6.90% | |
Cash paid for amounts included in present value of operating lease liabilities | $ 43,414 | $ 42,773 | |
Right-of-use assets obtained in exchange for operating lease liabilities | $ 50,667 | $ 17,670 |
Repurchases of Common Stock - Schedule of Repurchase of Common Stock (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Repurchases Of Common Stock [Abstract] | ||||
Amount repurchased under Board-approved share repurchase program | $ 100,015 | $ 0 | $ 267,433 | $ 38,111 |
Amount repurchased in connection with the vesting of employee restricted stock grants | 287 | 329 | 17,051 | 3,170 |
Total amount repurchased (based on trade dates) | $ 100,302 | $ 329 | $ 284,484 | $ 41,281 |
Repurchases of Common Stock - Additional Information (Details) $ in Millions |
Jul. 03, 2021
USD ($)
|
---|---|
Repurchases Of Common Stock [Abstract] | |
Authorized share repurchase program | $ 600 |
Remaining authorized stock purchase plan | $ 500 |
Revenue Recognition - Schedule of Deferred Contract Assets and Deferred Contract Liabilities (Details) - USD ($) $ in Thousands |
Jul. 03, 2021 |
Jan. 02, 2021 |
---|---|---|
Deferred Contract Assets included in: | ||
Deferred contract assets | $ 71,291 | $ 64,569 |
Deferred Contract Liabilities included in: | ||
Deferred contract liabilities | 93,041 | 84,977 |
Other current assets | ||
Deferred Contract Assets included in: | ||
Other current assets | 25,293 | 26,593 |
Other non-current assets | ||
Deferred Contract Assets included in: | ||
Other non-current assets | 45,998 | 37,976 |
Other current liabilities | ||
Deferred Contract Liabilities included in: | ||
Other current liabilities | 33,228 | 35,288 |
Other non-current liabilities | ||
Deferred Contract Liabilities included in: | ||
Other non-current liabilities | $ 59,813 | $ 49,689 |
Revenue Recognition - Additional Information (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Disaggregation of Revenue [Line Items] | ||||
Revenue recognized, included in beginning deferred contract liability balance | $ 8 | $ 10 | $ 15 | $ 18 |
SleepIQ Technology | ||||
Disaggregation of Revenue [Line Items] | ||||
Estimated product life | 4 years 6 months | |||
Transferred at Point in Time | Revenue from Contract with Customer Benchmark | Timing of Transfer of Goods or Services Concentration Risk | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue recognized at a point in time | 98.00% | 97.00% | 98.00% | 97.00% |
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 484,316 | $ 284,938 | $ 1,052,572 | $ 757,504 |
Retail stores | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 426,653 | 206,476 | 915,841 | 643,125 |
Online, phone, chat and other | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 57,663 | $ 78,462 | $ 136,731 | $ 114,379 |
Revenue Recognition - Schedule of Sales Return Liability (Details) - USD ($) $ in Thousands |
6 Months Ended | |
---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Sales Return Liability [Roll Forward] | ||
Balance at beginning of year | $ 24,765 | $ 19,809 |
Additions that reduce net sales | 42,272 | 30,901 |
Deductions from reserves | (45,820) | (33,514) |
Balance at end of period | $ 21,217 | $ 17,196 |
Stock-based Compensation Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock based compensation expense | $ 5,968 | $ 5,033 | $ 12,385 | $ 7,084 |
Income tax benefit | 1,473 | 1,218 | 3,071 | 1,714 |
Total stock-based compensation expense, net of tax | 4,495 | 3,815 | 9,314 | 5,370 |
Stock awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock based compensation expense | 5,218 | 4,440 | 11,027 | 5,846 |
Stock options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock based compensation expense | $ 750 | $ 593 | $ 1,358 | $ 1,238 |
Profit Sharing and 401(k) Plan (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Profit Sharing And 401 (k) Plan [Abstract] | ||||
Employee compensation deferral (as a percent) | 50.00% | |||
Employer contributions | $ 1.8 | $ 0.5 | $ 3.7 | $ 2.1 |
Net Income (Loss) per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jul. 03, 2021 |
Apr. 03, 2021 |
Jun. 27, 2020 |
Mar. 28, 2020 |
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Earnings Per Share [Abstract] | ||||||
Net income (loss) | $ 22,250 | $ 66,634 | $ (12,630) | $ 39,140 | $ 88,884 | $ 26,510 |
Reconciliation of weighted-average shares outstanding: | ||||||
Basic weighted-average shares outstanding (in shares) | 24,371,000 | 27,923,000 | 24,874,000 | 27,890,000 | ||
Dilutive effect of stock-based awards (in shares) | 823,000 | 0 | 995,000 | 633,000 | ||
Diluted weighted-average shares outstanding (in shares) | 25,194,000 | 27,923,000 | 25,869,000 | 28,523,000 | ||
Net income per share – basic (in dollars per share) | $ 0.91 | $ (0.45) | $ 3.57 | $ 0.95 | ||
Net income per share – diluted (in dollars per share) | $ 0.88 | $ (0.45) | $ 3.44 | $ 0.93 |
Commitments and Contingencies (Details) - USD ($) $ in Thousands |
6 Months Ended | |
---|---|---|
Jul. 03, 2021 |
Jun. 27, 2020 |
|
Warranty Liabilities [Roll Forward] | ||
Balance at beginning of year | $ 12,152 | $ 11,345 |
Additions charged to costs and expenses for current-year sales | 7,863 | 4,965 |
Deductions from reserves | (9,235) | (4,789) |
Changes in liability for pre-existing warranties during the current year, including expirations | (237) | (89) |
Balance at end of period | $ 10,543 | $ 11,432 |
COVID-19 Pandemic (Details) |
3 Months Ended |
---|---|
Jun. 27, 2020 | |
Average | |
Unusual or Infrequent Item, or Both [Line Items] | |
Percentage of stores that are closed | 47.00% |
"9-\@VE!#AH1I
MU$^+^\4()&SA,_6 &PO=V]R:W-H
M965TSE!WYQ40L:8S5+*:_H;.*Y50I@?HO%*=KZ'X
M9WIV)3WI?IW7PO$< YU7PK$67EUB8^LE;>G3&[0NBW6<'E.?<*:=6Z!!2]06
M(-7)JYU;H 6$X:18>^8Y#/;LSOK) (#:EPS$9C$--NA.^N$ H-^BH2@P( R
M5X,"H$U[=0*>T @%)DG-?D-WEDDBLP-T9YF.1(RQZNR94VQLH^0F>][>+ -Z
MLZ9]VWHMY_"]6::#"?F!=AP=4F.#);O8\W1GF5Y?FL(QDR1CA^O.,J"I&G'U
M=QBF8T_]T=:E:+P6"4;V;-U9!G1GP\ADD80=.VA[E@&@0[Y/?*PZ$ !4X%.U
M4P*)1013P[JXQ!C?KT_K #H'& :D($ZQL?42=?SI[5R7Q4"Q":8@@*">@@!"
M:@@W3*BG(-.M=Y*[5\X_Q+4 >>,5V:T8Z;\.A/OJ]5OJD"2:
M$KENNC7L[ZQJ-A10J$/,+8&85GB>U1%J6ZFB2DBAULM2A:+WAGPEN7!4W=6]
MIE;L0"OO$H#OH///3MG#+'23H-::UEB&$%Z2JP0V8(&Q0'U-TGE>\.(9>MG,
M0EJ8WM"J4[IDFX[6R6=T$-@WI"^5TM%1;0J@H U\1=\IY1.:0QNTBQ:J15'1
M1C8 T)H-=*"88[^T:3:W7MH:UL*Z0K4BN(FE#'PX"T/T4[#=6-7[RS)6E.>:7%?UQH'8.=+Y0
MRJXW+L'FKVCZ&U!+ P04 " !)@?Y2S2@S;1H% !C# &0 'AL+W=O
M
D[["FSDDY27K>_F,OET!__MJ$:('B/ZSQ\"K
MP< K-O#J6[)^+8,.E/,[KX*R41)<=V7U&W7^53;MWW=K%9^40.^VTJM2Q%J)
MPJ$$-N ;/@7$6LJ(+Y6VTA9:&A$@J-"$$;ZR.O(87,#2L?9*\9.@GT23BJJH
MJ (E68M<$<:34:H5_^J:A?+BQOG6^>012;O.B^.CH[\SXV[ F;.E5:= ))AJRH\Q.W
M]@R+ *6Y=3")@FD2P2TND!4>F&SY>_$ZCLF1.)\&\21\M]X^8!80!AT(*:S4
MR+DQ&)F"&X=O&13,5B\M=AH6+>8/M[@1NK1#N'1[*8**E5MXA&/(BQX&'3D:
M#S-LYU+2R[2I[2YK*+4PNL;,"=3I+QGFUC,(M69 "[]@9@V^$<:C[Y0.
'
M@)\"]NY@S'PF2V.>_>2VFD:)%P022O0,G#X[F(.4GHAD_&TYH^Y(#SP'(6:#KIJ*>6%6_F3LJXM",.Y:\10^P-NOU#*
MODU\;]"T=M,_4$L#!!0 ( $F!_E)!L_X=H ( ((' 9 >&PO=V]R
M:W-H965T
)EC1<:"_:"9SH?.N8,RLL05TW=B_9DT?FR""\&4
M_47K&CL \*)26A0-&3(H**^?^+FIPQ8!=+H)04,(]@G1*X2P(83OC1 UA.B]
M$>*&8*V[M7=;N G6.$VD6"-IT*!F7FSU+1OJ1;GIDYF6<$J!I].O!*JLT$VGA.6G8!FNCHA-8&J4XM<.B'A:=@P4V6#2 )5$:C,#B'A:?@X4V6#R Q:'G
M!W98TL.2<[#(!DL&L"B$NV:'I3TL/0>+;;!T N#+ GML*R'99.PKP6%[\5&
M4VE#9@-DAH,,VY&^=W0I;QHJ-.&(-_ZS(Z_P'=%V9_&&)<